CA-HAI-ROBOTICS
22.3.2022 11:44:04 CET | Business Wire | Press release
HAI ROBOTICS , the pioneer in Autonomous Case-handling Robot (ACR) systems for warehouse logistics, will present its highly flexible totes-to-person warehouse automation solution at this year’s MODEX 2022 show, Booth C4585 at Georgia World Congress Center in Atlanta from March 28th to 31st.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220322005613/en/
With its robots being exhibited also by MHS, SVT Robotics, GreyOrange and Tompkins Robotics, the company will demonstrate alongside its strategic partners how its state-of-the-art warehousing technology complements the global supply chain.
Days ahead of MODEX 2022, HAI ROBOTICS announced new partnerships with Tompkins Robotics and Storage Solutions. The partnerships will see technology and solutions developed by HAI ROBOTICS being applied to various industries across North America.
Brian Reinhart, Vice President of Sales and Marketing at HAI ROBOTICS U.S., said the company would have a full display of its commitment to customers, partners and the U.S. market at the show after being in the market for over a year.
"It's a very exciting time for HAI ROBOTICS as we continue our expansion and growth in the U.S." he said. "In order to best serve the market and accommodate the requests of our end users, we are developing a robust, strong, and valuable partner network."
Reinhart, a veteran in the material-handling industry, says: "In a short time, we have planted deep roots in the U.S."
In addition to existing customers and partners, HAI ROBOTICS has established a U.S. HQ in Fremont, CA, a fully functional Demo Center with a decentralized sales and implementation strategy, positioning employees in 15 different states across the country.
The company's "ambitious goals have hiring, onboarding, and training of talented individuals as a top priority." "We want to be where our customers are to best serve them. We are committed to providing our partners with the best industry products, solutions, and service," he said.
Exhibits
The company's exhibits this year include two types of ACR robots and one workstation that were crafted to explore the full potentials of order-fulfillment efficiency, deployment flexibility and scalability in a goods-to-person order-handling context.
The HAIPICK A42T robot to be displayed is an evolution of the company’s IFOY 2021 "Best in Intralogistics" title earner. With a telescopic lift function that can flexibly adjust its picking height, it can handle bins (totes or cartons) at a storage height ranging from 0.28 to 10 meters.
It can carry 8 loads to feed goods-to-person workstations in one move, and shuttle between different storage areas without hindrance.
The HAIPICK A3 fork-lifting robot is a new invention that targets wider warehousing scenarios in addition to bin storage. It handles goods that don’t require a container, such as tires, trays and boards that can be lifted by a fork from the bottom. Its fork-lifting design brings an extra benefit of higher storage density, since spaces between neighboring bins can be reduced. This type of robot is a good match with working environments where control for dust, static and pollution is strict.
In addition to high flexibility, the HAIPICK robots outperform other goods-transporting robots by bringing every inch under the ceiling available for storage. However, it is the teamwork with the HAIPORT-powered Workstation that maximizes a warehouse’s throughput capacity.
A HAIPORT-powered Workstation , which can fulfill orders at in-bound and out-bound, involves collaboration between HAIPICK robots, HAIPORT and conveyor belts. HAIPORT is an automatic loading and unloading machine that can be docked with ACR robots and conveyor belts. At a HAIPORT-powered Workstation, multiple loads of totes or cartons are unloaded from the HAIPICK robots at the entry side of the HAIPORT, then transferred onto the conveyor belts for sorting per system orders and moved to the exit side of the HAIPORT, where they were fetched by robots for the next round of order processing.
The HAIPORT-powered Workstation is suitable for medium-to-large warehouses that have high throughput requirement of at least 400 bins per hour. It's machine rate can deliver 600 bins per hour to an operator. It suits for extensive storage scenarios in which medium and small-sized bins are used, such as raw materials, small electronics, apparel, medicine, retails and 3PL industries that have large number of SKUs.
ABOUT HAI ROBOTICS
HAI ROBOTICS, a trailblazer of Autonomous Case-handling Robot (ACR) systems, is committed to providing efficient, intelligent, flexible, and customized warehouse automation solutions through robotics technology and AI algorithms. It aims to create value for each factory and logistics warehouse. The HAIPICK ACR system, independently developed in 2015, is the world's first of its kind.
Founded in 2016 in Shenzhen, China, HAI ROBOTICS has offices in the U.S., Europe, Japan, Southeast Asia, Hong Kong and Taiwan, serving customers from more than 30 countries and regions.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220322005613/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
